Oncos Therapeutics Ltd, a private, clinical-stage biotechnology company focused on the development and commercialization of targeted oncolytic immunotherapies for solid tumors, announced today that the United States Food and Drug Administration (FDA) and European Medicines Agency (EMA) have granted orphan drug designation for CGTG-102, a granulocyte-macrophage colony stimulatin...
New therapy improves life span in melanoma patients with brain metastases, SLU researchers find
8/02/2013
In a retrospective study, Saint Louis University researchers have found that patients with melanoma brain metastases can be treated with large doses of interleukin-2 (HD IL-2), a therapy that triggers the body's own immune system to destroy the cancer cells...
Researchers have established a 3-D microfluidic system to study a biological process known as endothelial sprouting. This process represents an early step in new blood vessel growth called angiogenesis. Breakthroughs in an integrated understanding of angiogenesis will benefit researchers in broad biomedical fields, including cancer, vascular science, and tissue engineering...
New 3-D colonoscopy eases detection of precancerous lesions
8/02/2013
MIT researchers have developed a new endoscopy technology that could make it easier for doctors to detect precancerous lesions in the colon. Early detection of such lesions has been shown to reduce death rates from colorectal cancer, which kills about 50,000 people per year in the United States...
Anemia link: iron-rich foods may ward off dementia
8/02/2013
Researchers have discovered that low iron levels in blood and anemia could be linked to increased risks for dementia, according to a study published in the journal Neurology. Anemia occurs when the number of red blood cells or concentrations of hemoglobin, a protein inside red blood cells, are low...
New target for the fight against cancer and diseases as a result of excessive blood vessel formation
8/01/2013
New blood vessel formation (angiogenesis) stimulates the growth of cancer and other diseases. Anti-angiogenic inhibitors slow down cancer growth by disrupting the blood supply to the tumor. To date, the success of these treatments is limited by resistance, poor efficiency and harmful side effects...
Better prospects for metastatic cancer survival - mouse study
8/01/2013
Researchers have found a way to preserve gut health in mice that have been given very high doses of chemoradiotherapy. They say if the same works in humans, it could be a huge step towards treatments that eradicate metastatic cancer...
Researchers uncover how SMIP004 kills prostate cancer cells
8/01/2013
One major hallmark of cancer cells is their ability to survive under stressful conditions. A new study spearheaded by researchers at Sanford-Burnham Medical Research Institute reveals how a promising anticancer compound called SMIP004 specifically kills prostate cancer cells by compromising their ability to withstand environmental stress...
Some women with abnormal breast lesions may avoid surgery
8/01/2013
Surgery is not always necessary for women with a type of breast tissue abnormality associated with a higher risk of cancer, according to a new study published online in the journal Radiology. Researchers said that periodic imaging and clinical exam are effective in these patients when radiology and pathology findings are benign and concordant, or in agreement...
Tomosynthesis reduces breast cancer screening recall rate
8/01/2013
Digital tomosynthesis is an effective tool for reducing the recall rate in breast cancer screening, according to a new study published online in the journal Radiology. Digital mammography is the gold standard for breast cancer screening, but may yield suspicious findings that turn out not to be cancer...